Inventor · disambiguated record
Chi Ching Mak
Also filed as: MAK CHI C · MAK CHI CHING
35 granted patents·13 pending applications·426 citations·filing 2005–2025
97Inventor score
Files withSAMUMED LLC16BIOSPLICE THERAPEUTICS INC15TARGEGEN INC8DART NEUROSCIENCE CAYMAN LTD4GONG XIANCHANG2
Top patents by PatentIndex Score
48 records- 0198US9745271B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2015·Granted Aug 29, 2017·58 cites·16 claims
- 0297US7528143B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Granted May 5, 2009·220 cites·44 claims
- 0395US11548872B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jan 10, 2023·2 cites·37 claims
- 0495US9951048B1Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Apr 24, 2018·13 cites·30 claims
- 0595US7825246B2Bi-aryl meta-pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2007·Granted Nov 2, 2010·40 cites·9 claims
- 0694US10287267B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted May 14, 2019·7 cites·30 claims
- 0793US10947217B2Isoquinolin-3-YL carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Mar 16, 2021·4 cites·40 claims
- 0892US8604042B2Bi-aryl meta-pyrimidine inhibitors of kinasesNORONHA GLENN·Filed 2010·Granted Dec 10, 2013·29 cites·5 claims
- 0990US11673881B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2021·Granted Jun 13, 2023·1 cites·42 claims
- 1090US11174244B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2019·Granted Nov 16, 2021·3 cites·50 claims
- 1188US10544128B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Jan 28, 2020·2 cites·42 claims
- 1287US10100038B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Oct 16, 2018·3 cites·30 claims
- 1386US10106527B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Oct 23, 2018·3 cites·39 claims
- 1486US7691858B2Kinase inhibitors and methods of use thereofTARGEGEN INC·Filed 2007·Granted Apr 6, 2010·11 cites·7 claims
- 1585US12281097B2Isoquinolin-3-yl carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Granted Apr 22, 2025·0 cites·21 claims
- 1685US8030487B22-amino—5-substituted pyrimidine inhibitorsTARGEGEN INC·Filed 2007·Granted Oct 4, 2011·10 cites·34 claims
- 1785US7456176B2Benzotriazine inhibitors of kinasesTARGEGEN INC·Filed 2005·Granted Nov 25, 2008·11 cites·34 claims
- 1881US10556885B2Isoquinolin-3-YL carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Feb 11, 2020·1 cites·30 claims
- 1979US10508099B2Isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Dec 17, 2019·1 cites·64 claims
- 2078US10934297B25-heteroaryl substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Mar 2, 2021·1 cites·28 claims
- 2176US9150572B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Oct 6, 2015·2 cites·3 claims
- 2276US9102674B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2014·Granted Aug 11, 2015·2 cites·35 claims
- 2375US10604514B26-(5-membered heteroaryl)isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Mar 31, 2020·1 cites·35 claims
- 2475US2025129104A17h-pyrrolo[2,3-d]pyrimidines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2574US2025171466A1Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2672US9675605B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE (CAYMAN) LTD·Filed 2015·Granted Jun 13, 2017·1 cites·7 claims
- 2767US12134625B2Pyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Granted Nov 5, 2024·0 cites·12 claims
- 2865US10744128B26-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereofSAMUMED LLC·Filed 2019·Granted Aug 18, 2020·0 cites·24 claims
- 2965US2025206746A14-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3065US2023167133A17h-pyrrolo[2,3-d]pyrimidines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3164US11713320B25-heteroaryl substituted indazole-3-carboxamides and preparation and use thereofBIOSPLICE THERAPEUTICS INC·Filed 2020·Granted Aug 1, 2023·0 cites·24 claims
- 3261US2023192686A11h-pyrrolo[2,3-b]pyridines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 3360US2024199649A14-aminopyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3459US9956213B2Substituted naphthyridine and quinoline compounds as MAO inhibitorsDART NEUROSCIENCE CAYMAN LTD·Filed 2017·Granted May 1, 2018·0 cites·18 claims
- 3559US2024002391A14-alkoxypyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3656US10669240B25-substituted indazole-3-carboxamides and preparation and use thereofSAMUMED LLC·Filed 2017·Granted Jun 2, 2020·0 cites·16 claims
- 3756US2007161645A1Thiazole inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 3854US10413537B26-(5-membered heteroaryl)isoquinolin-3-yl-(5-membered heteroaryl) carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Sep 17, 2019·0 cites·23 claims
- 3954US2009275569A1Benzotriazine Inhibitors of KinasesGONG XIANCHANG·Filed 2008·Application pending·0 cites
- 4051US2025340575A14-aminopyrrolo[2,1-f][1,2,4]triazines and preparation and uses thereofBIOSPLICE THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 4151US2007149508A1Six membered heteroaromatic inhibitors targeting resistant kinase mutationsTARGEGEN INC·Filed 2006·Application pending·0 cites
- 4249US8178490B2Polybasic bacterial efflux pump inhibitors and therapeutic uses thereofGLINKA TOMASZ·Filed 2009·Granted May 15, 2012·0 cites·15 claims
- 4345US10703748B2Diazanaphthalen-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted Jul 7, 2020·0 cites·17 claims
- 4444US10653688B26-(6-membered heteroaryl and aryl)isoquinolin-3-yl carboxamides and preparation and use thereofSAMUMED LLC·Filed 2018·Granted May 19, 2020·0 cites·24 claims
- 4543US8481536B2Benzotriazine inhibitors of kinasesGONG XIANCHANG·Filed 2010·Granted Jul 9, 2013·0 cites·5 claims
- 4643US7807841B2Spiro-containing compounds and compositions as modulators of steroid hormone nuclear receptorsIRM LLC·Filed 2006·Granted Oct 5, 2010·0 cites·23 claims
- 4742US2022062240A1Methods of treating cancer using a clk inhibitorBIOSPLICE THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 4841US2006247250A1Pyrimidine inhibitors of kinasesTARGEGEN INC·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Chi Ching Mak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →